Featured Research

from universities, journals, and other organizations

When do newborns first feel cold?

Date:
June 21, 2010
Source:
University of Southern California
Summary:
Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study. The finding adds to understanding of the cold sensing protein TRPM8.

Cold sensing neural circuits in newborn mice take around two weeks to become fully active, according to a new study.

The finding adds to understanding of the cold sensing protein TRPM8 (pronounced trip-em-ate), first identified in a Nature paper in 2002 by USC College professor David McKemy.

McKemy's study, published online by Neuroscience, shows that the cold sensing circuit starts to develop in utero but does not mature until well after birth.

"About three or four days before the animal is born, the protein is expressed. However, the axons of these nerves going into the spinal cord are not fully formed until probably two weeks after birth," said McKemy, an assistant professor of neurobiology.

The delay in development of cold sensing is plausible, McKemy added.

"In the womb, when would we ever feel cold?"

By contrast, mice are born with a keen sense of smell, which they need to breast feed successfully.

Direct study of the cold sensing protein TRPM8 in humans is not yet possible. While sensory development differs in mice and humans -- mice are born blind, for example -- the study suggests a possible biological basis for findings of altered cold sensitivity in premature infants.

In a 2008 study of temperature sensation by the Institute of Child Health at University College London, researchers found that 11-year-old children born prematurely were less sensitive to temperature than those born at term.

"This is consistent with our observations that the circuitry is not fully developed until after birth, thus anything that disrupts this formation at this important stage could have long-term effects," McKemy noted.

"There are other reports that injury and inflammation in rodent models that occur during the [prenatal] period lead to altered temperature sensitivity as well as altered neural circuits."

The USC researchers tracked development of cold sensing through mice genetically engineered to express a green fluorescent protein whenever TRPM8 was produced.

TRPM8 is one in a class of proteins known as ion channels. Their purpose is to "turn on the cell" when they receive a stimulus. TRPM8 senses both painful cold and the soothing cold of menthol-based creams.

How one protein can convey both sensations is unknown. McKemy speculated that neurons differ in their internal architecture, with each tuned to accept either painful or pleasant cold signals from TRPM8.

One goal of TRPM8 research is to understand the molecular mechanisms of sensation, in the hope of developing better drugs for relief of chronic pain states, such as the extreme sensitivity to cold experienced by some diabetes patients.

"If you want to understand conditions like cold allodynia, which is cold pain, you need to find exactly what are the targets," McKemy said.

"If we understand the basic nuts and bolts of the molecules and neurons and how they detect pain normally," McKemy said, "then perhaps we can figure out why we detect pain when we shouldn't."

For a demonstration of how mice lacking TRPM8 lose much of their cold sensitivity, view the video at http://www.nature.com/nature/journal/v448/n7150/suppinfo/nature05910.html

McKemy's collaborators on the study were first author Yoshio Takashima, now a postdoctoral researcher at Carnegie Mellon University, and Le Ma, assistant professor of cell and neurobiology at the Keck School of Medicine of USC.

The National Institutes of Health funded the research.


Story Source:

The above story is based on materials provided by University of Southern California. The original article was written by Carl Marziali. Note: Materials may be edited for content and length.


Journal Reference:

  1. David D. McKemy, Werner M. Neuhausser, David Julius. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature, 2002; 416 (6876): 52 DOI: 10.1038/nature719

Cite This Page:

University of Southern California. "When do newborns first feel cold?." ScienceDaily. ScienceDaily, 21 June 2010. <www.sciencedaily.com/releases/2010/06/100617141008.htm>.
University of Southern California. (2010, June 21). When do newborns first feel cold?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/06/100617141008.htm
University of Southern California. "When do newborns first feel cold?." ScienceDaily. www.sciencedaily.com/releases/2010/06/100617141008.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins